Anti-C Peptide antibody [7E10] (ab1974)

Overview

• Product nameAnti-C Peptide antibody [7E10]
  See all C Peptide primary antibodies
• Description
  Mouse monoclonal [7E10] to C Peptide
• SpecificityThis antibody binds with equal efficiency to the human free C-peptide and C-peptide region in proinsulin molecules. This antibody does not cross-react with human, bovine, porcine and mouse/rat insulin. Antigenic determinants identified by the antibody are in the three-dimensional structure generated by N- and C-terminal regions of C-peptide separated by beta-turn at position 47-50 of proinsulin. Affinity (Kd) > 1 x 10^-8.
• Tested applicationsSuitable for: ELISA, RIA, Sandwich ELISAmore details
• Species reactivity
  Reacts with: Human
  
• Immunogen

  Recombinant fragment.

• General notesConcentration varies from lot to lot and can be provided on request. Competitive ELISA or RIA detection of C-peptide in human serum after immunospecific removal of proinsulin (with solid-phased Mabs to human proinsulin).

  
  

  C Peptide is part of the molecule of Proinsulin, that consists of three parts: C Peptide and two long strands of amino acids (called the alpha and beta chains) that later become linked together to form the insulin molecule. From every molecule of proinsulin, one molecule of insulin plus one molecule of C Peptide are produced. C peptide is released into the blood stream in equal amounts to insulin. A test of C peptide levels will show how much insulin the body is making. Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.

Properties

• FormLiquid
• Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
• Storage bufferPreservative: 0.1% Sodium Azide
  Constituents: PBS, pH 7.4
• Concentration information loading...
• PurityProtein A purified
• Purification notesPurity is tested by electrophoresis.
• Primary antibody notesC Peptide is part of the molecule of Proinsulin, that consists of three parts: C Peptide and two long strands of amino acids (called the alpha and beta chains) that later become linked together to form the insulin molecule. From every molecule of proinsulin, one molecule of insulin plus one molecule of C Peptide are produced. C peptide is released into the blood stream in equal amounts to insulin. A test of C peptide levels will show how much insulin the body is making. Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.
• ClonalityMonoclonal
• Clone number7E10
• Myelomax63-Ag8.653
• IsotypeIgG1
• Light chain typekappa
• Research areas
  • Signal Transduction
  • Growth Factors/Hormones
  • Insulin / Insulin-like

  • Neuroscience
  • Neurology process
  • Metabolism

  • Metabolism
  • Types of disease
  • Cancer

Associated products

• ELISA pair antibody
  • Anti-C Peptide antibody [5B8] (ab1973)

Applications

Target

• FunctionInsulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.
• Involvement in diseaseDefects in INS are the cause of familial hyperproinsulinemia (FHPRI) [MIM:176730].
  Defects in INS are a cause of diabetes mellitus insulin-dependent type 2 (IDDM2) [MIM:125852]. IDDM2 is a multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
  Defects in INS are a cause of diabetes mellitus permanent neonatal (PNDM) [MIM:606176]. PNDM is a rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy.
  Defects in INS are a cause of maturity-onset diabetes of the young type 10 (MODY10) [MIM:613370]. MODY10 is a form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
• Sequence similaritiesBelongs to the insulin family.
• Cellular localizationSecreted.

• Target information above from: UniProt accession P01308 The UniProt Consortium
  The Universal Protein Resource (UniProt) in 2010
  Nucleic Acids Res. 38:D142-D148 (2010) .

  Information by UniProt
• Database links
  • Entrez Gene: 3630 Human
  • Omim: 176730 Human
  • SwissProt: P01308 Human
  • Unigene: 272259 Human
• Alternative names
  • IDDM 2 antibody
  • IDDM2 antibody
  • ILPR antibody

  • ins antibody
  • INS_HUMAN antibody
  • Insulin A chain antibody
  • IRDN antibody
  • MODY10 antibody
  • Proinsulin antibody

  see all